UK markets closed
NIKKEI 225
39,631.06 +47.98 (+0.12%) HANG SENG
17,718.61 +2.11 (+0.01%) CRUDE OIL
83.37 +1.83 (+2.24%) GOLD FUTURES
2,341.70 +2.10 (+0.09%) DOW
39,169.52 +50.66 (+0.13%) Bitcoin GBP
49,999.83 +856.23 (+1.74%)
Monte Rosa Therapeutics, Inc. (GLUE)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.7400 |
| Open | 3.7500 |
| Bid | 3.9200 x 200 |
| Ask | 3.9800 x 100 |
| Day's range | 3.7500 - 4.1900 |
| 52-week range | 2.4400 - 8.8400 |
| Volume | |
| Avg. volume | 208,411 |
| Market cap | 240.933M |
| Beta (5Y monthly) | 1.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Institutional investors own a significant stake of 40% in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)
Key Insights Institutions' substantial holdings in Monte Rosa Therapeutics implies that they have significant influence...
- GuruFocus.com
Monte Rosa Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview
Insight into Financial Performance and Strategic Developments Amidst Ongoing Clinical Trials
- Zacks
Recent Price Trend in Monte Rosa Therapeutics (GLUE) is Your Friend, Here's Why
Monte Rosa Therapeutics (GLUE) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
© 2024 Yahoo. All rights reserved.